Andrew Bellinger - Dec 14, 2022 Form 4 Insider Report for Verve Therapeutics, Inc. (VERV)

Role
CSO & CMO
Signature
/s/ Andrew Ashe, as Attorney-in-Fact for Andrew Bellinger
Stock symbol
VERV
Transactions as of
Dec 14, 2022
Transactions value $
$103,320
Form type
4
Date filed
12/16/2022, 04:00 PM
Previous filing
Dec 2, 2022
Next filing
Feb 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERV Common Stock Options Exercise $103K +36K +543.07% $2.87* 42.6K Dec 14, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VERV Stock Option (right to buy) Options Exercise $0 -36K -16.67% $0.00 180K Dec 14, 2022 Common Stock 36K $2.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The remaining shares underlying this option, which was granted on September 16, 2020, vest in equal monthly installments until September 16, 2024.